Indegene helped a top 20 biopharmaceutical company operating 100+ brands across 20+ markets with 10,000+ annual assets and 7 agency partners "shift right" on the material review maturity curve amid 1.5X digital asset growth and 40% longer time-to-market. Challenges spanned nonstandard processes, varying maturity levels across brands/affiliates, sparse metrics tracking limiting agency oversight, and extensive as-is inefficiencies. Indegene's software standardized workflows, enhanced visibility into operations, optimized agency performance, and delivered comprehensive metrics—streamlining reviews for faster market delivery and scalable efficiency.

Join for free to read